Nifty
Sensex
:
:
18562.75
62504.80
50.00 (0.27%)
211.16 (0.34%)

Pharmaceuticals & Drugs - Domestic

Rating :
62/99

BSE: 506820 | NSE: ASTRAZEN

3360.95
28-Nov-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 3359.80
  • 3388.55
  • 3347.00
  • 3359.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9711
  •  326.61
  •  3620.00
  •  2445.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,393.13
  • 91.11
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,944.66
  • 0.30%
  • 15.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.67%
  • 18.54%
  • FII
  • DII
  • Others
  • 2.49%
  • 1.12%
  • 1.18%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.51
  • 7.13
  • -1.06

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 13.24
  • -6.52

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 18.91
  • -5.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 108.49
  • 109.71
  • 108.84

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.16
  • 19.16
  • 19.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 61.77
  • 61.50
  • 63.50

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma gets import, market permission for Forxiga tablets
    28th Nov 2022, 14:59 PM

    The receipt of this permission paves way for the launch of Forxiga tablets of 10 mg in India for the specified additional/expanded indication

    Read More
  • AstraZeneca Pharma gets Import, Market permission in Form CT-20 from DCGI for Olaparib Film-Coated tablets
    20th Aug 2022, 09:48 AM

    The receipt of this permission paves way for the launch of Olaparib Film-Coated Tablets 100 mg and 150 mg (Lynparza) in India

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.